πŸ‡ΊπŸ‡Έ FDA
Patent

US 12319693

Crystalline forms of CFTR modulators

granted A61PA61P11/00

Quick answer

US patent 12319693 (Crystalline forms of CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P11/00